Poseida Therapeutics, Inc.

New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Apr 22, 2019
Total Offering

$150,000,000

Amount Sold

$142,120,007

Investors

17

First Sale

Mar 19, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Eric Ostertag
Related Person
Mark Gergen
Related Person
Matthew Spear
Related Person
David Hirsch
Related Person
Marcea Bland Lloyd
Related Person
Catherine J. Mackey
Related Person
Sean Murphy
Related Person
John Schmid
Related Person
Noah Berkowitz
Related Person

Company

Poseida Therapeutics, Inc.

9390 Towne Centre Drive

SAN DIEGO, CA, 92121

858-779-3100

SEC Filing

0001661460-19-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free